Drug Manufacturers - General Stocks in India
Finoron tracks 14 listed companies in the Drug Manufacturers - General industry, with a combined market capitalisation of ₹1.43 L Cr. The median price-to-earnings ratio across its profitable companies is 43.7. The largest by market capitalisation are GlaxoSmithKline Pharmaceuticals, Rubicon Research and Pfizer.
All 14 companies by market capitalisation
| Company | Price | Change | Market Cap | P/E |
|---|---|---|---|---|
| GlaxoSmithKline PharmaceuticalsGLAXO | ₹2,829.00 | -0.01% | ₹47,700 Cr | 44.6 |
| Rubicon ResearchRUBICON | ₹1,679.30 | +0.19% | ₹27,748 Cr | 96.2 |
| PfizerPFIZER | ₹4,060.00 | +0.34% | ₹18,303 Cr | 24.9 |
| Marksans PharmaMARKSANS | ₹337.50 | +0.03% | ₹15,269 Cr | 29.6 |
| Sanofi Consumer Healthcare IndiaSANOFICONR | ₹3,980.00 | +0.22% | ₹9,099 Cr | 34.1 |
| Sanofi IndiaSANOFI | ₹3,120.20 | -0.40% | ₹7,232 Cr | 22.3 |
| Senores PharmaceuticalsSENORES | ₹1,344.30 | +0.00% | ₹6,241 Cr | 47.9 |
| SMS PharmaceuticalsSMSPHARMA | ₹475.90 | +0.39% | ₹4,448 Cr | 42.8 |
| Sai Parenteral'sSAIPARENT | ₹509.95 | +0.70% | ₹2,226 Cr | 113.8 |
| NGL Fine-ChemNGLFINE | ₹2,975.50 | +2.78% | ₹1,795 Cr | 31.4 |
| TTK HealthcareTTKHLTCARE | ₹1,031.10 | -1.37% | ₹1,457 Cr | 19.7 |
| KopranKOPRAN | ₹271.80 | +0.37% | ₹1,375 Cr | 52.4 |
| CORONA RemediesCORONA | ₹2,125.00 | +0.66% | — | 64.9 |
| Symbiotec PharmalabSYMBIOTEC | ₹1,023.00 | -0.10% | — | 68.5 |